Upcoming Cancer Medicines Will Test Limits of Acceptable Drug Prices

August 3, 2015

Reuters (Hirschler, 8/3) reported that several “new cancer drug cocktails set to reach the market in the next few years will test the limits of premium pricing for life-saving medicines, forcing company executives to consider fresh market strategies. … The growing reluctance of governments and private insurers to fund very expensive drugs, even remarkably effective ones, points to a showdown as manufacturers mix and match therapies that harness the immune system to fight tumors.”